Faculty profile

Julia Upton

Back to faculty

Associate ProfessorInstitute of Medical ScienceUniversity of Toronto

Julia Upton

Associate Professor

Institute of Medical Science

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
41 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

844

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Clinical and genetic findings of individuals tested using the navigateAPDS genetic testing program
Annals of Allergy, Asthma and Immunology · 2026
‘What’ and ‘How’ to Measure in Allergy and Clinical Immunology: A Systematic Review of Core Outcome Sets and Outcome Harmonisation Processes
Clinical and Experimental Allergy · 2026
Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of Immunity.
Journal of clinical immunology · 2026

All 60 publications

Latest funding

RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
CIHR · 2023 · Co-investigator
$19,999,843
PLEDGE: Policies Laws and Emergency Department Guidelines for Epinephrine auto-injector use
CIHR · 2022 · Co-investigator
$100,000
SORT: Safety of OIT in a Randomized Trial
CIHR · 2022 · Co-investigator
$100,000

All 6 grants and awards

60 publications.

Clinical and genetic findings of individuals tested using the navigateAPDS genetic testing program

Campbell E, Garkaby J, Upton J, Park N, Samad M, Hogue M, Harper JR, Relan A, McLaughlin H, Williams KW

Annals of Allergy, Asthma and Immunology20262 citationsOpen Access

DOI: 10.1016/j.anai.2025.07.015

‘What’ and ‘How’ to Measure in Allergy and Clinical Immunology: A Systematic Review of Core Outcome Sets and Outcome Harmonisation Processes

Demidova A, Kiknavelidze N, Purtskhvanidze K, Alieva E, Ebrahimnejad M, Konchina S, Nurmeeva A, Matkovskii I, Elmurzaeva E, Davtian S

Clinical and Experimental Allergy2026Open Access

DOI: 10.1111/cea.70251

Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of Immunity.

Porto LLTN, Yazji D, Unninayar D, Decaluwe H, Derfalvi B, Palma A, Issekutz T, Kalashnikova T, Murguía-Favela L, Pham-Huy A, Rubin T, Suresh S, Upton J, Wright NAM, Chapdelaine H, Falcone EL, Top KA, Sadarangani M, Vinh DC, Barrett L, Oldford S, Langlois MA, Arnold C, Zhang T, Ramsay T, Cowan J, VISID study investigators

Journal of clinical immunology2026Open Access

DOI: 10.1007/s10875-026-02021-1 PMID: 42034835

The pro-doc-tivity pause: Health economic benefits of collegial connection.

Barisciano L, Tsoulis M, Bailey SJ, Parikh AD, Verdi M, Soffer GK, Bingemann TA, Upton J, Abrams EM, Anagnostou A, Rathkopf M, Demain JG, Oppenheimer J, Zecca T, Narisety S, Blatman KH, Shaker SW, Miano M, Shaker M

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2026

DOI: 10.1016/j.anai.2026.04.014 PMID: 41999987

Authors' response.

Anvari S, Gupta M, Nicolaides R, Morita H, Upton J, Varshney P, Ruffner M, Baker MG

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2026

DOI: 10.1016/j.anai.2025.11.015 PMID: 41638786

Clinical Warning Signs in Detecting Inborn Errors of Immunity in Children: A Diagnostic Accuracy Systematic Review.

Aden A, Jemide I, Islam T, Iakovleva E, Andreeva M, Buonsenso D, Hoffnung LA, Comberiati P, Peroni D, Giovannini M, Asmanov A, Fedorova L, Gadetskaya S, Upton J, Schoos AM, Hsu P, Korsunskiy A, Korsunskiy I, Munblit D

The journal of allergy and clinical immunology. In practice2026

DOI: 10.1016/j.jaip.2026.01.026 PMID: 41638305

Peanut Oral Immunotherapy in Children: An Italian Single-Center Retrospective Cohort Study.

Pessina B, Sertori C, Barni S, Catamerò F, Liccioli G, Paladini E, Sarti L, Tomei L, Upton J, Valleriani C, Mori F, Giovannini M

Nutrients2026

DOI: 10.3390/nu18081252 PMID: 42075065

Biologics and Novel Therapeutics in Food Allergy.

Anderson B, Pascal C, Butler MGK, Chin AR, Long AJ, Sindher SB, Anagnostou A, Arasi S, Bégin P, Ciaccio CE, Eiwegger T, Fiocchi A, Fleischer DM, Garcia-Llorett M, Kim EH, Leonard S, Maskatia ZR, Perrett KP, Shreffler W, Upton J, Chinthrajah RS

The journal of allergy and clinical immunology. In practice2026

DOI: 10.1016/j.jaip.2026.01.044 PMID: 41956612

Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE

Matthew Greenhawt, Deborah Albright, Sara Anvari, Nicolette Arends, Peter D. Arkwright, Philippe Bégin, Katharina Blümchen, Terri A. Brown‐Whitehorn, Heather Cassell, Edmond S. Chan, Christina E. Ciaccio, A. Deschildre, Amandine Divaret‐Chauveau, Stacy L. Dorris, Morna J. Dorsey, George Du Toit, Thomas Eiwegger, Michel Erlewyn‐Lajeunesse, David Mark Fleischer, Lara S. Ford, Maria Garcia-Lloret, Jonathan O’B Hourihane, Nicola Jay, Stacie M. Jones, Edwin Kim, Kirsten M. Kloepfer, Stephanie Ann Leonard, Guillaume Lezmi, Phil Lieberman, Jeanne M. Lomas, et al. (61 authors)

The Journal of Allergy and Clinical Immunology In Practice202516 citationsOpen Access

DOI: 10.1016/j.jaip.2025.02.004 PMID: 39956162

Transparent Reporting of Pediatric Clinical Trial Interventions: TIDieR-Children and Adolescents.

Goren K, Lai VKW, Baba A, Smith M, Allegaert K, Butcher NJ, Fernandes R, Gill PJ, Hartling L, Juszczak E

Pediatrics202510 citations

DOI: 10.1542/peds.2025-072867

RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network

Co-investigatorCIHR2023Team Grant: Pediatric Rare Disease Clinical Network

Principal investigators: Lacaze-Masmonteil, Thierry; Anagnostou, Evdokia; Baribeau, Danielle A; Batthish, Michelle; Bernard, Geneviève; Bernier, Francois P; Butcher, Nancy J; Campbell, Craig Gordon N; Cross, Andrea; Dyack, Sarah; Gantt, Soren M; Gravel, Christopher; Haddad, Elie; Heath, Anna; Kelly, Lauren; King, Alexandra; Klassen, Terry P; Knisley, Lisa; Lai, Meng-Chuan; Lewis, Tamorah R; Marwaha, Ashish K; McBride, Kim; Mitchell, John J; Moore Hepburn, Charlotte; Mooser, Vincent E; Myers, Kenneth A; Offringa, Martin; Oskoui, Maryam; Portales-Casamar, Elodie; Pot, Sara; Potter, Elizabeth K; Richer, Lawrence P; Round, Jeff; Stewart, Breanne; Subbarao, Padmaja; Thebaud, Bernard; Turvey, Stuart E; Ward, Leanne M; Wong-Rieger, Durhane; Wright, Nicola A; Yeh, Ann E.

Keywords: Child Health; Data Science; Drug Development; Paediatric Clinical Research Units; Paediatric Clinical Trials; Patient And Public Involvement; Patient Registries; Precision Medicine; Rare Diseases; Real-World Evidence

$19,999,843

PLEDGE: Policies Laws and Emergency Department Guidelines for Epinephrine auto-injector use

Co-investigatorCIHR2022Project Grant

Principal investigators: Ben-Shoshan, Moshe

Keywords: Allergy; Anaphylaxis; Health Economics; Health Guidelines; Immunology; Integrated Knowledge Translation; Intervention Research; Laws; Population Health; Public Health Policies

$100,000

SORT: Safety of OIT in a Randomized Trial

Co-investigatorCIHR2022Project Grant

Principal investigators: Ben-Shoshan, Moshe

Keywords: Allergic Reaction Management/Treatment; Anaphylaxis; Food Allergy; Oral Immunotherapy; Prospective Cohort

$100,000

COVID-19 Vaccine Responses among African Canadians: Sustainability of Immune Responses and Safety Profiles.

Co-investigatorCIHR2021Operating Grant: Emerging COVID-19 Research Gaps and Priorities - Vaccines

Principal investigators: Allen, Upton D

Keywords: African Canadians; Immune Response; Safety; Sars-Cov-2; Vaccines

$467,999

COVID-19 Vaccine Responses among African Canadian Children with and without Sickle Cell Disease

Co-investigatorCIHR2021Op. Gr.:Emerging COVID-19 Res. Gaps & Priorities (July 2021) - Immune Responses

Principal investigators: Allen, Upton D

Keywords: African Canadians; Children; Immune Response; Sars-Cov-2; Sickle Cell Disease; Vaccines

$482,223

A 15 months, double-Blind, randomized controlled trial comparing 18 weeks of two doses of Omalizumab to placebo to accelerate a symptom-driven Oral immunotherapy schedule in subjects aged 6 to 25 years with Multiple food allergies (BOOM).

Co-investigatorCIHR2019Project Grant

Principal investigators: Bégin, Philippe

Keywords: Food Allergy; Omalizumab; Oral Immunotherapy

$267,750

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Julia Upton

Research

Latest papers

Latest funding

Clinical and genetic findings of individuals tested using the navigateAPDS genetic testing program

‘What’ and ‘How’ to Measure in Allergy and Clinical Immunology: A Systematic Review of Core Outcome Sets and Outcome Harmonisation Processes

Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of Immunity.

The pro-doc-tivity pause: Health economic benefits of collegial connection.

Authors' response.

Clinical Warning Signs in Detecting Inborn Errors of Immunity in Children: A Diagnostic Accuracy Systematic Review.

Peanut Oral Immunotherapy in Children: An Italian Single-Center Retrospective Cohort Study.

Biologics and Novel Therapeutics in Food Allergy.

Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE

Transparent Reporting of Pediatric Clinical Trial Interventions: TIDieR-Children and Adolescents.

RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network

PLEDGE: Policies Laws and Emergency Department Guidelines for Epinephrine auto-injector use

SORT: Safety of OIT in a Randomized Trial

COVID-19 Vaccine Responses among African Canadians: Sustainability of Immune Responses and Safety Profiles.

COVID-19 Vaccine Responses among African Canadian Children with and without Sickle Cell Disease

A 15 months, double-Blind, randomized controlled trial comparing 18 weeks of two doses of Omalizumab to placebo to accelerate a symptom-driven Oral immunotherapy schedule in subjects aged 6 to 25 years with Multiple food allergies (BOOM).

Frequent collaborators

Moshe Ben-Shoshan

Ann Clarke

Jennifer Gerdts

Derek Chu

Rodrick Lim

Jennifer Protudjer

Judy Morris

Jocelyn Gravel

Eyal Grunebaum

Thomas Eiwegger

Bruce Mazer

Philippe Bégin

Karina Top

Adelle Atkinson

Sneha Suresh

Juthaporn Cowan

Manish Sadarangani

Douglas Mack

Hugo Chapdelaine

Aleixo Muise

Marc-André Langlois

Yaron Avitzur

Michaela Cada

Melinda Solomon

Margaret Marcon

Thomas Poder